StockWatch
·
Medical Specialities
Quarterly ResultMay 12, 2026, 04:23 PM

Lumexa Imaging Swings to Q1 Net Income of $1.7M; EPS $0.02

AI Summary

Lumexa Imaging Holdings, Inc. reported a significant financial turnaround for Q1 2026, swinging to a net income of $1.7 million, or $0.02 per diluted share, compared to a net loss of $7.7 million in Q1 2025. Total revenues increased by 3.1% to $252.5 million. The company also saw a substantial improvement in cash flow from operations, turning positive at $2.9 million, and a 45.3% reduction in interest expense, largely due to debt paydown from its December 2025 IPO.

Key Highlights

  • Net income of $1.7 million in Q1 2026, a swing from $(7.7) million loss in Q1 2025.
  • Diluted EPS of $0.02 in Q1 2026, compared to $(0.11) loss in Q1 2025.
  • Total revenues increased 3.1% to $252.5 million from $245.0 million year-over-year.
  • Net cash from operating activities turned positive at $2.9 million, from $(14.0) million used.
  • Interest expense decreased 45.3% to $16.3 million from $29.8 million year-over-year.
  • Income from operations decreased 24.0% to $19.4 million from $25.5 million year-over-year.
  • Total equity grew to $599.6 million as of March 31, 2026, from $586.1 million.